← Open Payments lookup

KATIE LUEBKE: Open Payments

NPI 1225644776 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$706 in 27 payments from 8 companies in 2025. Trend: 2023 $964 · 2024 $676 · 2025 $706

Food & beverage: $706
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$171
Otsuka America Pharmaceutical, Inc.5$121
Alkermes, Inc.5$119
Vanda Pharmaceuticals Inc.4$106
Janssen Pharmaceuticals, Inc2$59
Neurocrine BioSciences, Inc.2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
E.R. Squibb & Sons, L.L.C.2$31

Products named: UZEDY, ABILIFY ASIMTUFII, FANAPT, ARISTADA, INVEGA SUSTENNA, INGREZZA, LYBALVI, CAPLYTA.

Industry payments across AZ — which companies pay providers there.